These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 19317627)

  • 1. Monitoring HIV treatment in resource-limited settings: reassuring news on the usefulness of CD4(+) cell counts.
    Fowler MG; Owor M
    J Infect Dis; 2009 May; 199(9):1255-7. PubMed ID: 19317627
    [No Abstract]   [Full Text] [Related]  

  • 2. Viral load testing in resource-limited settings.
    Schooley RT
    Clin Infect Dis; 2007 Jan; 44(1):139-40. PubMed ID: 17143830
    [No Abstract]   [Full Text] [Related]  

  • 3. HIV viral load monitoring in resource-limited regions: optional or necessary?
    Calmy A; Ford N; Hirschel B; Reynolds SJ; Lynen L; Goemaere E; Garcia de la Vega F; Perrin L; Rodriguez W
    Clin Infect Dis; 2007 Jan; 44(1):128-34. PubMed ID: 17143828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance profiles after different periods of exposure to a first-line antiretroviral regimen in a Cameroonian cohort of HIV type-1-infected patients.
    Soria A; Porten K; Fampou-Toundji JC; Galli L; Mougnutou R; Buard V; Kfutwah A; Vessière A; Rousset D; Teck R; Calmy A; Ciaffi L; Lazzarin A; Gianotti N
    Antivir Ther; 2009; 14(3):339-47. PubMed ID: 19474468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early treatment of HIV: implications for resource-limited settings.
    Hobbs CV; Essajee SM
    Curr Opin HIV AIDS; 2009 May; 4(3):222-31. PubMed ID: 19532054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of antiretroviral therapy in resource-poor settings: are outcomes comparable to those in the developed world?
    Lawn SD; Myer L; Wood R
    Clin Infect Dis; 2005 Dec; 41(11):1683-4; author reply 1684. PubMed ID: 16267745
    [No Abstract]   [Full Text] [Related]  

  • 7. Association-driven care and treatment: a model for community-based delivery of HIV/AIDS healthcare in resource-limited settings.
    Kassaye SG; Ndayishimiye F; Binswanger H; Sall AY; Machekano R; Israelski DM
    AIDS; 2006 Jul; 20(11):1561-2. PubMed ID: 16847415
    [No Abstract]   [Full Text] [Related]  

  • 8. Treating HIV: when to start, who should treat, and still missing many.
    Laurence J
    AIDS Read; 2008 Jun; 18(6):285-6. PubMed ID: 18623889
    [No Abstract]   [Full Text] [Related]  

  • 9. HIV-1 viral load testing cost in developing countries: what's new?
    Rouet F; Rouzioux C
    Expert Rev Mol Diagn; 2007 Nov; 7(6):703-7. PubMed ID: 18020900
    [No Abstract]   [Full Text] [Related]  

  • 10. Real world reassurance about a misperception.
    Winslow DL
    AIDS Alert; 2009 Feb; 24(2):19-20. PubMed ID: 19219949
    [No Abstract]   [Full Text] [Related]  

  • 11. Viral load monitoring in resource-limited settings: a medical and public health priority.
    Ford N; Roberts T; Calmy A
    AIDS; 2012 Aug; 26(13):1719-20. PubMed ID: 22874478
    [No Abstract]   [Full Text] [Related]  

  • 12. Choice of an initial antiretroviral regimen in the resource-limited setting: the cost of virologic failure.
    Campbell TB
    Clin Infect Dis; 2008 Sep; 47(5):723-5. PubMed ID: 18662135
    [No Abstract]   [Full Text] [Related]  

  • 13. Dried blood spots perform well in viral load monitoring of patients who receive antiretroviral treatment in rural Tanzania.
    Johannessen A; Garrido C; Zahonero N; Sandvik L; Naman E; Kivuyo SL; Kasubi MJ; Gundersen SG; Bruun JN; de Mendoza C
    Clin Infect Dis; 2009 Sep; 49(6):976-81. PubMed ID: 19663598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scaling up antiretroviral treatment in resource-limited settings: successes and challenges.
    Katabira ET; Oelrichs RB
    AIDS; 2007 Jul; 21 Suppl 4():S5-10. PubMed ID: 17620753
    [No Abstract]   [Full Text] [Related]  

  • 15. Scale-up of HIV care and treatment: can it transform healthcare services in resource-limited settings?
    El-Sadr WM; Abrams EJ
    AIDS; 2007 Oct; 21 Suppl 5():S65-70. PubMed ID: 18090271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1 drug resistance mutations in children who failed non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy.
    Sungkanuparph S; Apiwattanakul N; Thitithanyanont A; Chantratita W; Sirinavin S
    Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):83-8. PubMed ID: 19323038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Slow accumulation of HIV resistance mutations: implications for resource-limited settings?
    Stevens WS
    J Infect Dis; 2009 Sep; 200(5):670-2. PubMed ID: 19604045
    [No Abstract]   [Full Text] [Related]  

  • 18. Virologic and immunologic responses to antiretroviral therapy among HIV-1 and HIV-2 dually infected patients: case reports from Abidjan, Côte d'Ivoire.
    Borget MY; Diallo K; Adje-Toure C; Chorba T; Nkengasong JN
    J Clin Virol; 2009 May; 45(1):72-5. PubMed ID: 19375979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [HIV infection in women].
    Haberl A
    MMW Fortschr Med; 2009 Apr; 151(18):45-6, 48. PubMed ID: 19769075
    [No Abstract]   [Full Text] [Related]  

  • 20. Establishment of drug-resistant HIV-1 in latent reservoirs.
    Dahl V; Palmer S
    J Infect Dis; 2009 May; 199(9):1258-60. PubMed ID: 19338473
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.